申请人:HECHT Sidney
公开号:US20130267546A1
公开(公告)日:2013-10-10
The present disclosure provides biologically active compounds of formula (I): and pharmaceutically acceptable salts thereof: compositions comprising these compounds, and methods of using these compounds in a variety of applications, such as treatment or suppression of diseases associated with decreased mitochondrial function resulting in diminished ATP production and/or oxidative stress and/or lipid peroxidation.
本公开提供了式(I)的生物活性化合物及其药学上可接受的盐:包含这些化合物的组合物,以及使用这些化合物在多种应用中的方法,例如治疗或抑制与减少线粒体功能相关的疾病,导致ATP产生减少和/或氧化应激和/或脂质过氧化。